What's it like choosing between endocrine therapy options after mastectomy?

These treatment decisions after mastectomy can feel overwhelming, especially when weighing the different impacts each option might have on daily life and future health. The factors that often help people navigate this choice include their age, family planning goals, existing side effect tolerance, and detailed discussions with their oncology team about their specific cancer characteristics and risk factors. Hopefully others in this community who've faced similar decisions will share their real-world experiences with both approaches to help give you a clearer picture of what each path might involve.

Hi Jennifer. May I ask how old you are? I was 52 when I was diagnosed and I was not in menopause yet. Ultimately, I went onto an Aromatase Inhibitor (which is usually given to menopausal women) rather than Tamoxifen. In part, it was because I was approaching menopause anyway but also because the other medications that were part of my treatment seemed to partner well with the Aromatase Inhibitor. On that treatment plan, I was in a No Evidence of Disease (NED) status for 9 months and then had a recurrence.